Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category

Diabetes Therapy · Published 2026-05-09 · DOI 10.1007/s13300-026-01875-3

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s13300-026-01875-3

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Real-World Performance of the MiniMed 780G Advanced Hybrid Closed Loop Automated Insulin Delivery System in Greece · Diabetes Therapy · 2026 · Same journal
Cardiometabolic Effects of Semaglutide in Individuals with Type 2 Diabetes in the United Arab Emirates: Real-World 12-Month Outcomes and Predictors of Response · Diabetes Therapy · 2026 · Same journal
Insulin Injection Behaviors and Association with Glycemic Outcomes in Patients with Diabetes: A Real-World Survey in Spain · Diabetes Therapy · 2026 · Same journal
Innovative Diabetes Therapies and Impact on Peripheral and Autonomic Diabetic Neuropathies: A State-of-the-Art Review · Diabetes Therapy · 2026 · Same journal
A Retrospective Analysis of the Clinical Characteristics and Treatment Patterns Among Individuals with Diabetes Receiving Insulin Therapy in Japan: The Insulin JP2DB Study · Diabetes Therapy · 2026 · Same journal
Glycemic Patterns Assessed by Continuous Glucose Monitoring in People with Type 2 Diabetes Treated with Insulin Glargine 100 U/mL in Primary Care: The GPDetect Study · Diabetes Therapy · 2026 · Same journal
Beyond Coverage Expansion: Exploring Persistent Barriers to CGM Utilization in the Clinical Environment · Diabetes Therapy · 2026 · Same journal
Rewriting Diabetes Therapy: How Incretin Modulation is Transforming Cardiovascular and Renal Outcomes · Diabetes Therapy · 2026 · Same journal
Continuous Glucose Monitoring Before and After Simultaneous Pancreas–Kidney Transplantation: Insights from a Real-World Clinical Setting · Diabetes Therapy · 2026 · Same journal
Blood Glucose Monitoring Expert Group and Best Practice Recommendation—FITTER BiG · Diabetes Therapy · 2026 · Same journal